Breast Cancer Patients Left With Permanent Hair Loss
Taxotere (Docetaxel) is an FDA approved drug that is used during chemotherapy to help treat breast cancer, non-small cell lung cancer, head and neck cancer, stomach cancer and metastatic prostate cancer. Taxotere is administered intravenously and is member of the family of drugs called Taxanes. The main purpose of Taxotere is to prevent cancer cells from growing and spreading.
Claims are currently being filed against Sanofi-Aventis by patients who have suffered permanent hair loss as a result of being prescribed Taxotere (Docefrez) or Docetaxel (Generic Brand). According to Lawyers, the manufacturer failed to properly warn patients of the risks of Taxotere. If the patients and doctors would have known the risk of permanent hair loss, the physicians would have prescribed other chemotherapy drugs, such as Taxol.
In December 2015, the FDA did acknowledge that Taxotere can result in permanent hair loss. The FDA has yet to recall Taxotere. However, the FDA is requiring a new warning label regarding permanent hair loss
If you or a loved one suffered permanent hair loss after taking the breast cancer medication Taxotere (docetaxel), contact tortlawteam today. We can help determine if you or a loved one may be entitled to compensation.